Peer2Peer: The Podcast

Galaxy: First Clinical Experiences

Host Dr Ben LaHood welcomes Mr Allon Barsam and Ms Purvi Thomson from OCL Vision in London to discuss their first clinical experiences with the new RayOne Galaxy spiral IOL. They delve into the innovative science and technology behind the lens, which provides a full range of vision with minimal dysphotopsia. They also share insights from their first implantations and discuss the promising early results.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Post-Laser Patients & Pre-op Lens Calculations

Professor Graham Barrett is joined by Professor Dan Reinstein and Mr Darshak Patel to discuss the benefits of RayOne EMV for post corneal refractive surgery patients.  They dive into how to match the right IOL to the patient’s corneal profile, and specifically spherical aberration, while stressing the need for comprehensive testing on patients before surgery.
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.© 2024 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Post-laser Patients: Understanding Aberrations

Professor Graham Barrett is joined by Professor Dan Reinstein and Mr Darshak Patel to discuss the benefits of RayOne EMV for post corneal refractive surgery patients, focusing on the importance of tailored approaches through careful diagnostics and lens selection to reduce the risk of post-operative complications.
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

The Different Ways RayPRO Can Benefit A Surgeon

At AUSCRS 2024, Dr Ben LaHood led a live podcast featuring Professor Paul Ursell, Dr Josefina Botta, and Mr Luke Anderson to explore the diverse advantages of the RayPRO tool for surgeons. Tune in to this 10-minute discussion to hear each surgeon’s unique perspective on its benefits.
 
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

RayOne EMV in My US Practice: Billing Insights & Modern Patient Benefits

Join Dr. Ben LaHood and Dr. Blake Williamson as they delve into RayOne EMV and its successful integration into Dr. Williamson's US practice. Learn why Dr. Williamson chooses this lens, how it enhances patient satisfaction, and the innovative billing strategies he employs. Whether you're a US surgeon looking to optimize your financial strategy or interested in modern patient care solutions, this episode provides valuable insights into the benefits and outcomes of using RayOne EMV. Discover how this lens stands out in a busy practice and why it's a strong choice for today's patients.
 
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

The Sophi Story 4 years in, with Dr Erik Mertens

What factors drive a surgeon to switch to a different phaco system? Is it about customising settings to match your preferences, ensuring seamless integration with your operating team, or optimising efficiency? Following Rayner's recent acquisition of Sophi, Dr Ben LaHood delves into these questions with Dr Erik Mertens, who has been using the Sophi Phaco System for four years. In this insightful conversation, Dr Mertens shares his experiences and highlights the innovative features of the Sophi system that are inspiring surgeons worldwide to make the switch.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries. © 2024 Rayner Group, all rights reserved. Rayner and Sophi are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Glaucoma Patients: Benefits of RayOne EMV

Dr Ben LaHood and Dr Rajen Desai discuss the complexities of selecting the right IOL for patients with glaucoma. They emphasise the need for a personalised approach to IOL selection while taking into consideration a multitude of factors, such a disease severity, patient lifestyles, and pupil size.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Rayner & Sophi: A Match Made in Heaven

In January 2024, Rayner, a global leader in ophthalmic solutions, acquired THIS AG, the innovative Swiss manufacturer of the Sophi phacoemulsification machine. In this episode, Prof Paul Ursell, president of UKISCRS in the United Kingdom, engages in an exclusive interview with the CEO of Rayner, and the Vice President of R&D for Sophi and Managing Director of This AG, to explore the details of the acquisition and discuss the future of this collaboration.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner and Sophi are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Enhancing Patient Understanding in Cataract Surgery

Hosted by Dr Ben LaHood, this special episode is in collaboration with Ophthalpreneurs and brings together the founder Amanda Cardwell Carones, alongside Mr Allon Barsam for an insightful discussion, sharing valuable insights on the crucial importance of enhancing patient counselling. Topics cover: mastering pre-surgery counselling, breaking communication barriers, and providing personalised care to achieve optimal outcomes in cataract and refractive surgery.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

OMIDRIA Special Ep. 6 Innovations in Dropless Cataract Surgery Solutions

In this episode of ‘Peer2Peer: The Podcast’, Dr. Eric Donnenfeld and Dr. John Hovanesian discuss a recent clinical study evaluating clinical efficacy and patient preference for a dropless treatment regimen following cataract surgery, as well as other innovative dropless solutions.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. OMIDRIA Podcasts are for the attention of USA HCPs only. OMIDRIA is distributed by Rayner Surgical Inc.
Rayner, the Rayner logo, OMIDRIA®, and the OMIDRIA logo are proprietary marks of Rayner. © 2024 Rayner Group, all rights reserved. US-OM-2300050 01/24
IMPORTANT SAFETY INFORMATION OMIDRIA® must be added to irrigating solution prior to use and is contraindicated in patients with known hypersensitivity to any of its ingredients. Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported ocular adverse reactions at ≥2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.